Assignee

Morphotek, Inc.

Patents = 65

Forward Citations = 301

where 'Filed Patents' based on already Granted Patents

where 'Inventors Filed' based on already Granted Patents

68 inventors (with patents filed for the assignee):

MorphoTek, Inc. is a biopharmaceutical company dedicated to the discovery, development, and commercialization of innovative antibody-based therapeutics. With a focus on cancer treatments, Morphotek utilizes its proprietary antibody discovery technologies to deliver targeted therapies that have the potential to improve patient outcomes. Through ongoing research and partnerships, the company continues to advance novel antibody candidates and contribute to the progress of medical science.

This text is generated by artificial intelligence and may not be accurate.

Please report any incorrect information to support@idiyas.com